Adolfo Cotter,MD

Brain-Mind Interface

Dr. Cotter practices Telemedicine in Primary Care. Conducts a competent, highly responsive Telemedicine practice since 2012, treating a variety of medical conditions from simple to very complex. Proficient with electronic medical records using a wide range of software packages and other forms of computing. Dr. Cotter also practiced Medicine doing Home Care, Urgent Care and Hospital Work.

Dr. Cotter has medical licenses in the states of Michigan, Indiana, and telehealth registration in the states of Minnesota and Florida. The links to the states medical boards are: Florida, http://www.flhealthsource.gov/telehealth/ Minnesota, https://mn.gov/boards/medical-practice/ Indiana, https://mylicense.in.gov/everification/ Michigan, https://www.michigan.gov/lara/0,4601,7-154-89334_72600_85566—,00.html

Dr. Adolfo Cotter founded Cognimetrix in 2007, motivated by a tremendous personal interest in the use of brain imaging data in the development of bionic based software to enhance creativity and intelligence.

Throughout his career, Dr. Cotter has performed brain imaging research in academic institutions such as Unversity of Toronto, University of Pennsylvania, and Emory University. He has also conducted brain imaging research for commercial companies such as at Cerebral Diagnostics.

Dr. Cotter has given lectures in Brain Imaging and attended numerous Brain Imaging meetings where he has presented his research projects. He has experience in brain imaging data acquisition and analysis for technologies such as PET, SPECT, MRI, fMRI and EEG. During his brain imaging analysis work, he has done biostatistics using a variety of software programs.

Imaging Apoptosis in the Human Brain

Imaging neuronal cell death is an emerging field in neuroimaging. It can have many implications. In Alzheimer’s disease we will be able to evaluate if there is cell death, and the actual amount of it happening. In Stroke we will be able to evaluate the penumb zone and the response to treatment. In Cancer we will be able to evaluate the response to treatment by measuring the ratio of dead cancerous cells to healthy brain tissue. In Head Trauma we will be able to evaluate the progression of pathology and if it responds to treatment. Here is an interesting article that discusses the utility of the F18-ML-10  PET  tracer for imaging apoptosis in Stroke:

Reshef A et al, Molecular Imaging of Neurovascular Cell Death in Experimental Cerebral Stroke by  PET ; J Nucl Med 2008; 49 1520-1528

Adolfo Cotter, MD

May 09/2010

Adolfo Cotter, MD's avatar

Posted by:

Adolfo Cotter, MD

Leave a comment